Fragment-Based Drug Discovery
A Practical Approach
Fragment-based drug discovery (FBDD) is a new paradigm in drugdiscovery that utilizes very small molecules - fragments of largermolecules. It is a faster, cheaper, smarter way to do drugdiscovery, as shown by the number of pharmaceutical companies thathave embraced this approach and the biotechnology companies who usefragments as their sole source of drug discovery.Fragment-Based Drug Discovery: A Practical Approach is aguide to the techniques and practice of using fragments in drugscreening. The emphasis is on practical guidance, with procedures,case studies, practical tips, and contributions from industry.Topics covered include:* an introdu…
Mehr
CHF 153.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Shapiro, Michael (Hrsg.)
- ISBN: 978-0-470-72156-8
- EAN: 9780470721568
- Produktnummer: 13799373
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2008
- Seitenangabe: 296 S.
- Plattform: PDF
- Masse: 7'706 KB
Über den Autor
Edward R. Zartler, Strategy Consultant, Eli Lilly & Co.; Established the Fragment-based Drug Design paradigm at Eli Lilly. Michael J. Shapiro, Associate Professor of Pharmacy, University of Maryland School of Pharmaceutical Sciences; Industry experience at Lilley, Novartis and Sandoz.
3 weitere Werke von Edward R. (Hrsg.) Zartler:
Bewertungen
Anmelden